chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Vaccination site warmth; injection site became hard; very itchy; "at the injection site just a little redness, a little swelling and the muscle sore"; very swollen; Muscle soreness; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE INDURATION (injection site became hard), VACCINATION SITE PRURITUS (very itchy), VACCINATION SITE ERYTHEMA ("at the injection site just a little redness, a little swelling and the muscle sore") and VACCINATION SITE SWELLING (very swollen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026I20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA ("at the injection site just a little redness, a little swelling and the muscle sore"), VACCINATION SITE SWELLING (very swollen) and MYALGIA (Muscle soreness). On 14-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE INDURATION (injection site became hard) and VACCINATION SITE PRURITUS (very itchy). The patient was treated with CORTISONE (topical) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE INDURATION (injection site became hard), VACCINATION SITE PRURITUS (very itchy), VACCINATION SITE ERYTHEMA ("at the injection site just a little redness, a little swelling and the muscle sore"), VACCINATION SITE SWELLING (very swollen) and MYALGIA (Muscle soreness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included for high blood pressure medications.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Cough, Rhinorrhoea, Vaccination complication
Clinical narrative: Doesn't feel good in stomach; wasn't feeling well; running nose; cough; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (running nose), COUGH (cough), ABDOMINAL DISCOMFORT (Doesn't feel good in stomach) and VACCINATION COMPLICATION (wasn't feeling well ) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AZITHROMYCIN DIHYDRATE (AZITHROMYCIN +PHARMA) from 14-Jan-2021 to an unknown date and LORATADINE (LORTADINE) from 14-Jan-2021 to an unknown date for an unknown indication.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced RHINORRHOEA (running nose), COUGH (cough) and VACCINATION COMPLICATION (wasn't feeling well ). On 15-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (Doesn't feel good in stomach). At the time of the report, RHINORRHOEA (running nose), COUGH (cough), ABDOMINAL DISCOMFORT (Doesn't feel good in stomach) and VACCINATION COMPLICATION (wasn't feeling well ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded. The company physician considers the reported events as non-serious, because there is no apparent rationale to deal them as serious.
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (Wheezing) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced WHEEZING (Wheezing). At the time of the report, WHEEZING (Wheezing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Having difficulty sleeping; Soreness; Stiffness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Stiffness), INSOMNIA (Having difficulty sleeping) and VACCINATION SITE PAIN (Soreness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Stiffness) and VACCINATION SITE PAIN (Soreness). On an unknown date, the patient experienced INSOMNIA (Having difficulty sleeping). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Stiffness), INSOMNIA (Having difficulty sleeping) and VACCINATION SITE PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness postural, Vertigo
Clinical narrative: Cannot walk without falling/very bad vertigo; Dizziness on standing up; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Cannot walk without falling/very bad vertigo) and DIZZINESS POSTURAL (Dizziness on standing up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VERTIGO (Cannot walk without falling/very bad vertigo) and DIZZINESS POSTURAL (Dizziness on standing up). At the time of the report, VERTIGO (Cannot walk without falling/very bad vertigo) and DIZZINESS POSTURAL (Dizziness on standing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.; Sender's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Conjunctivitis, Headache, Hypoaesthesia, Magnetic resonance imaging, Neck pain
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of CONJUNCTIVITIS (conjunctivitis) and VACCINATION SITE WARMTH (Warm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), ALPRAZOLAM (XANAX) for Anxiety, ESCITALOPRAM OXALATE (LEXAPRO) for Depression, HYDROCHLOROTHIAZIDE for Fluid retention, METOPROLOL for Heart rate, ESTRADIOL for Hormonal imbalance, LOSARTAN for Hypertension, CENTRUM SILVER for immunity. On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CONJUNCTIVITIS (conjunctivitis) and VACCINATION SITE WARMTH (Warm). At the time of the report, CONJUNCTIVITIS (conjunctivitis) had not resolved and VACCINATION SITE WARMTH (Warm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jan-2021, Magnetic resonance imaging: The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment for the events included Ibuprofen, Eye drop for conjunctivitis right eye.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of CONJUNCTIVITIS (conjunctivitis) and VACCINATION SITE WARMTH (Warm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), ALPRAZOLAM (XANAX) for Anxiety, ESCITALOPRAM OXALATE (LEXAPRO) for Depression, HYDROCHLOROTHIAZIDE for Fluid retention, METOPROLOL for Heart rate, ESTRADIOL for Hormonal imbalance, LOSARTAN for Hypertension, CENTRUM SILVER for immunity. On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CONJUNCTIVITIS (conjunctivitis) and VACCINATION SITE WARMTH (Warm). At the time of the report, CONJUNCTIVITIS (conjunctivitis) had not resolved and VACCINATION SITE WARMTH (Warm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jan-2021, Magnetic resonance imaging: The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment for the events included Ibuprofen, Eye drop for conjunctivitis right eye.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Skin irritation, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: uncomfortable; irritaed; Reoccurrence of itching at the injection site; Reoccurrence of redness at the injection site; itching; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (uncomfortable), SKIN IRRITATION (irritaed), VACCINATION SITE PRURITUS (Reoccurrence of itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE ERYTHEMA (Reoccurrence of redness at the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site). On an unknown date, the patient experienced MALAISE (uncomfortable), SKIN IRRITATION (irritaed), VACCINATION SITE PRURITUS (Reoccurrence of itching at the injection site), VACCINATION SITE ERYTHEMA (Reoccurrence of redness at the injection site) and VACCINATION SITE PRURITUS (itching). At the time of the report, MALAISE (uncomfortable), SKIN IRRITATION (irritaed), VACCINATION SITE PRURITUS (Reoccurrence of itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE ERYTHEMA (Reoccurrence of redness at the injection site) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.   Treatment for the event included, ice, Benadryl.    This case was linked to MOD-2021-075764 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jan-2021: No specific follow-up information recorded. On 27-Jan-2021: No specific follow-up information recorded.; Sender's Comments:  MOD-2021-075764:Same patient, 2nd dose
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Nausea, Pyrexia
Clinical narrative: really did not feel good; weakness; nausea; a little bit of vomiting; headache; Her arm felt like a brick had punched her in the arm; chills; fever 100.6-102°F; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (really did not feel good), ASTHENIA (weakness), CHILLS (chills), PYREXIA (fever 100.6-102°F) and NAUSEA (nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 since 17-Nov-2020. Concomitant products included PARACETAMOL (TYLENOL).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced CHILLS (chills) and PYREXIA (fever 100.6-102°F). On an unknown date, the patient experienced VACCINATION COMPLICATION (really did not feel good), ASTHENIA (weakness), NAUSEA (nausea), VOMITING (a little bit of vomiting), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm felt like a brick had punched her in the arm). At the time of the report, VACCINATION COMPLICATION (really did not feel good), ASTHENIA (weakness), CHILLS (chills), PYREXIA (fever 100.6-102°F), NAUSEA (nausea), VOMITING (a little bit of vomiting), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm felt like a brick had punched her in the arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Nov-2020, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Tylenol for treatment. She also tried to sleep and drink more fluids. She is currently trying to get more rest.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination complication, Vaccination site pain, Vomiting
Clinical narrative: really did not feel good; weakness; nausea; a little bit of vomiting; headache; Her arm felt like a brick had punched her in the arm; chills; fever 100.6-102°F; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (really did not feel good), ASTHENIA (weakness), CHILLS (chills), PYREXIA (fever 100.6-102°F) and NAUSEA (nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 since 17-Nov-2020. Concomitant products included PARACETAMOL (TYLENOL).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced CHILLS (chills) and PYREXIA (fever 100.6-102°F). On an unknown date, the patient experienced VACCINATION COMPLICATION (really did not feel good), ASTHENIA (weakness), NAUSEA (nausea), VOMITING (a little bit of vomiting), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm felt like a brick had punched her in the arm). At the time of the report, VACCINATION COMPLICATION (really did not feel good), ASTHENIA (weakness), CHILLS (chills), PYREXIA (fever 100.6-102°F), NAUSEA (nausea), VOMITING (a little bit of vomiting), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm felt like a brick had punched her in the arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Nov-2020, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Tylenol for treatment. She also tried to sleep and drink more fluids. She is currently trying to get more rest.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue
Clinical narrative: Feeling little tired; Some diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feeling little tired) and DIARRHOEA (Some diarrhea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02532OA) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Feeling little tired) and DIARRHOEA (Some diarrhea). At the time of the report, FATIGUE (Feeling little tired) and DIARRHOEA (Some diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Headache, Nausea, Pain in jaw
Clinical narrative: Jaw pain; Tastebuds were off; Sick; Chills; Headache; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (Jaw pain), AGEUSIA (Tastebuds were off), VACCINATION COMPLICATION (Sick), CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN JAW (Jaw pain), AGEUSIA (Tastebuds were off), VACCINATION COMPLICATION (Sick), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nauseous). At the time of the report, PAIN IN JAW (Jaw pain), AGEUSIA (Tastebuds were off), VACCINATION COMPLICATION (Sick), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Jaw pain; Tastebuds were off; Sick; Chills; Headache; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (Jaw pain), AGEUSIA (Tastebuds were off), VACCINATION COMPLICATION (Sick), CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN JAW (Jaw pain), AGEUSIA (Tastebuds were off), VACCINATION COMPLICATION (Sick), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nauseous). At the time of the report, PAIN IN JAW (Jaw pain), AGEUSIA (Tastebuds were off), VACCINATION COMPLICATION (Sick), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: She had soreness; Redness; Swelling/large localized area in her arm which is now swollen; Itching; a delayed allergic reaction to the vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (She had soreness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling/large localized area in her arm which is now swollen), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE REACTION (a delayed allergic reaction to the vaccine) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included CIMETIDINE, OMEPRAZOLE and LORATADINE for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (She had soreness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling/large localized area in her arm which is now swollen), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE REACTION (a delayed allergic reaction to the vaccine). At the time of the report, VACCINATION SITE PAIN (She had soreness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling/large localized area in her arm which is now swollen), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE REACTION (a delayed allergic reaction to the vaccine) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included antihistamines.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Significant follow up included reported AE duration and outcome, and second dose vaccine details.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Swelling face, Swollen tongue
Clinical narrative: Lower inner face is swelling / sagging; Lower inner face is numb; tongue swelling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Lower inner face is swelling / sagging), HYPOAESTHESIA (Lower inner face is numb) and SWOLLEN TONGUE (tongue swelling) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced SWELLING FACE (Lower inner face is swelling / sagging), HYPOAESTHESIA (Lower inner face is numb) and SWOLLEN TONGUE (tongue swelling). At the time of the report, SWELLING FACE (Lower inner face is swelling / sagging), HYPOAESTHESIA (Lower inner face is numb) and SWOLLEN TONGUE (tongue swelling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication reported.   She took Benadryl in the morning and upper and middle face is better.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: He develop redness at injection site and the area is increasing around 4 cm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE ERYTHEMA (He develop redness at injection site and the area is increasing around 4 cm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (He develop redness at injection site and the area is increasing around 4 cm). At the time of the report, VACCINATION SITE ERYTHEMA (He develop redness at injection site and the area is increasing around 4 cm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Chills; Fever; Fatigue; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Body ache) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Body ache). At the time of the report, CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body ache) had resolved and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was unknown.  No treatment information provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Shortness of breath; Arm is red; Arm is hot; Swollen arm; Vaccination site blotchiness; Vaccination site pain; Vaccination site pruritus; Puffy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE SWELLING (Puffy) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE SWELLING (Puffy). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE SWELLING (Puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment medication was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Shortness of breath; Arm is red; Arm is hot; Swollen arm; Vaccination site blotchiness; Vaccination site pain; Vaccination site pruritus; Puffy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE SWELLING (Puffy) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE SWELLING (Puffy). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE SWELLING (Puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment medication was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Vaccination site pain
Clinical narrative: chills; headache; fever; arm pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), PYREXIA (fever) and VACCINATION SITE PAIN (arm pain at the injection site) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cholesterol, Hypertension and Diabetes. Previously administered products included for an unreported indication: ZOSTER. Concomitant products included PRAVASTATIN, DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA), LISINOPRIL and SEMAGLUTIDE (OZEMPIC) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced CHILLS (chills), HEADACHE (headache), PYREXIA (fever) and VACCINATION SITE PAIN (arm pain at the injection site). On 16-Jan-2021, CHILLS (chills), HEADACHE (headache), PYREXIA (fever) and VACCINATION SITE PAIN (arm pain at the injection site) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took 2 tablets of ibuprofen for treatment.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and NAUSEA (Nausea) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history). Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm looks red, swollen, warm and it spreads down to her arm; Arm looks red, swollen, warm and it spreads down to her arm; Arm looks red, swollen, warm and it spreads down to her arm; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Arm looks red, swollen, warm and it spreads down to her arm), VACCINATION SITE SWELLING (Arm looks red, swollen, warm and it spreads down to her arm) and VACCINATION SITE WARMTH (Arm looks red, swollen, warm and it spreads down to her arm) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 16-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Arm looks red, swollen, warm and it spreads down to her arm), VACCINATION SITE SWELLING (Arm looks red, swollen, warm and it spreads down to her arm) and VACCINATION SITE WARMTH (Arm looks red, swollen, warm and it spreads down to her arm). At the time of the report, VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Arm looks red, swollen, warm and it spreads down to her arm), VACCINATION SITE SWELLING (Arm looks red, swollen, warm and it spreads down to her arm) and VACCINATION SITE WARMTH (Arm looks red, swollen, warm and it spreads down to her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment for the event was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: nausea; pressure/terrible headache; felt horrible; feeling lightheaded; Felt like passing out; Very sore; Very tired/very exhuasted; Bad arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt horrible) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION COMPLICATION (felt horrible). At the time of the report, VACCINATION COMPLICATION (felt horrible) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Concomitant product use was not provided by the reporter.  Patient took advil 500mg and Ativan for her symptoms.    Most recent FOLLOW-UP information incorporated above includes: On 17-Jan-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Presyncope, Vaccination complication, Vaccination site pain
Clinical narrative: nausea; pressure/terrible headache; felt horrible; feeling lightheaded; Felt like passing out; Very sore; Very tired/very exhuasted; Bad arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt horrible) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION COMPLICATION (felt horrible). At the time of the report, VACCINATION COMPLICATION (felt horrible) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Concomitant product use was not provided by the reporter.  Patient took advil 500mg and Ativan for her symptoms.    Most recent FOLLOW-UP information incorporated above includes: On 17-Jan-2021: No specific follow-up information recorded.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysphonia, Fatigue, Headache, Myalgia
Clinical narrative: Sore arm; Headache; Fever; Chills; Muscle joint aches; Fatigue; Nausea; Hoarseness of voice; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle joint aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Aortic stenosis, SERTRALINE HYDROCHLORIDE (ZOLOFT) for Depression, LISINOPRIL for Hypertension, Aderol for focus, MULTIVITAMINS [VITAMINS NOS] and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for immunity.    On 25-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Dec-2020, the patient experienced VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle joint aches), FATIGUE (Fatigue), NAUSEA (Nausea) and DYSPHONIA (Hoarseness of voice). On 04-Jan-2021, VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle joint aches), FATIGUE (Fatigue), NAUSEA (Nausea) and DYSPHONIA (Hoarseness of voice) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment activities for event was reported as none.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Sore arm; Headache; Fever; Chills; Muscle joint aches; Fatigue; Nausea; Hoarseness of voice; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle joint aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Aortic stenosis, SERTRALINE HYDROCHLORIDE (ZOLOFT) for Depression, LISINOPRIL for Hypertension, Aderol for focus, MULTIVITAMINS [VITAMINS NOS] and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for immunity.    On 25-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Dec-2020, the patient experienced VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle joint aches), FATIGUE (Fatigue), NAUSEA (Nausea) and DYSPHONIA (Hoarseness of voice). On 04-Jan-2021, VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle joint aches), FATIGUE (Fatigue), NAUSEA (Nausea) and DYSPHONIA (Hoarseness of voice) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment activities for event was reported as none.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Vaccination site erythema, Vaccination site rash
Clinical narrative: red rash in the arm that's getting larger/ Larger rash 3-1/2 x 2-1/2 inches; darker red circle; hypersensvity reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (red rash in the arm that's getting larger/ Larger rash 3-1/2 x 2-1/2 inches), VACCINATION SITE ERYTHEMA (darker red circle) and HYPERSENSITIVITY (hypersensvity reaction) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included Neuropathy, Urinary tract infection (had for years), Blood pressure high, Tremor (essential tremor voicebox) in 2012, Osteoarthritis and Osteopenia. Concurrent medical conditions included Allergy to antibiotic (Experienced Hives) since 2002, Hives, Hay fever and House dust mite allergy. Concomitant products included DILTIAZEM from 15-Mar-2017 to an unknown date for Hypertension, CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]) and ZINC for Supplementation therapy, ASCORBIC ACID, OLIGOMERIC PROANTHOCYANIDIN, VACCINIUM MACROCARPON (CRANBERRY) for UTI, ESTRADIOL (ESTRACE), MULTIVITAMIN [VITAMINS NOS] and METHYLCELLULOSE (CITRUCEL) for an unknown indication.    On 02-Jan-2021 at 7:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE RASH (red rash in the arm that's getting larger/ Larger rash 3-1/2 x 2-1/2 inches), VACCINATION SITE ERYTHEMA (darker red circle) and HYPERSENSITIVITY (hypersensvity reaction). The patient was treated with HYDROCORTISONE for Rash, at a dose of UNK dosage form. On 21-Jan-2021, VACCINATION SITE RASH (red rash in the arm that's getting larger/ Larger rash 3-1/2 x 2-1/2 inches), VACCINATION SITE ERYTHEMA (darker red circle) and HYPERSENSITIVITY (hypersensvity reaction) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitants includes multivitamins for immunity and methylcellulose +vitamin D3 for an unknown indication. On 18-JAN-2021, patient went to physician and he said it was a localized reaction to Moderna vaccine. It was reported that no medicine required as it was not infected.   This case was linked to MOD-2021-214543 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up information received medical history, concomitant medications and outcome of the event was updated. On 08-Jun-2021: Follow-up information received captured medical history, concomitant medications, event and outcome updated.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (There's a lump in it), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 UNK. On an unknown date, the patient experienced VACCINATION SITE INDURATION (There's a lump in it), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE INDURATION (There's a lump in it), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications taken by the patient were not provided. Treatment activities for event was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Further information have been requested.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Nausea, Paraesthesia, Vaccination site pain
Clinical narrative: tingly sensation and numbness along her jaw and ear; Nausea; Headache; Sore arm; Whole right side of face went numb including her nose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE PAIN (Sore arm), HYPOAESTHESIA (Whole right side of face went numb including her nose) and PARAESTHESIA (tingly sensation and numbness along her jaw and ear) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE PAIN (Sore arm) and HYPOAESTHESIA (Whole right side of face went numb including her nose). On an unknown date, the patient experienced PARAESTHESIA (tingly sensation and numbness along her jaw and ear). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE PAIN (Sore arm) and HYPOAESTHESIA (Whole right side of face went numb including her nose) had not resolved and PARAESTHESIA (tingly sensation and numbness along her jaw and ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Within 15 minutes, she experienced nausea, headache, and a sore arm. About 45 minutes after receiving the vaccine, she noticed her whole right side of the face went numb including her nose. She described it as what it feels like after a "dental surgery numbing injection." Within 15 minutes of discovery, the numbness started to subside. Currently, the numbness has gotten better, but she still has a tingly sensation and numbness along her jaw and ear.  Concomitant product use was not provided by the reporter.  Treatment information not provided.